API & Intermediates

3D Heterocylcic and Carbocylcic API and Intermediates

LCC have developed efficient/scalable chemical processes to access the key chiral intermediates of selected API:

API & Intermediates: Niraparib

Niraparib

API & Intermediates: Larotrectinib

Larotrectinib

API & Intermediates: PPDA-001

PPDA-001




All stereoisomers of the functionalised chiral intermediates can also be supplied to support new drug discovery.For more information please contact our BD Director, Dr Joanne Johnson: joanne.johnson@liverpoolchirochem.com